Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2022

01-03-2022 | COVID-19 | Original Research

Health-Related Quality of Life Mildly Affected Following COVID-19: a Retrospective Pre-post Cohort Study with a Propensity Score–Matched Control Group

Authors: Brittany Lapin, PhD, Irene L. Katzan, MD

Published in: Journal of General Internal Medicine | Issue 4/2022

Login to get access

Abstract

Importance

Long-term health effects have been indicated following COVID-19; however, the impact of COVID-19 on health-related quality of life (HRQOL), including who may experience ongoing symptoms, is unknown.

Objective

To identify change in HRQOL following COVID-19 compared to pre-infection HRQOL and a matched control group, and identify predictors of patients who worsen.

Design

Retrospective pre-post cohort study with a matched control group.

Setting

Large healthcare system in northeast Ohio.

Participants

A total of 3,690 adult patients diagnosed with COVID-19 who completed HRQOL surveys during routine care for ambulatory visits before and after infection. Propensity-score 1:1 match was utilized to identify controls without COVID who completed HRQOL at two time points.

Main Outcomes

HRQOL was assessed with PROMIS Global Health: global mental and physical health summary scores. Pre- and post-COVID PROMIS Global Health was completed as part of routine care from 1/1/2019 to 2/29/2020 and 4/4/2020 to 11/1/2021, respectively, and extracted from the electronic health record.

Results

COVID-19 patients (mean age 53±15; 66% female) completed PROMIS Global Health in the year prior (median 11.1 months) and after diagnosis (median 7.8 months). Compared to before infection, COVID-19 patients had a significant reduction in global mental health and stable global physical health (−0.85 and 0.05 T-score points, respectively) with clinically meaningful reduction (≥5 T-score points) experienced by 27% and 23% of patients, respectively. Predictors of worsening global health included being female, having depression, being hospitalized for COVID-19, and better pre-COVID global health. Compared to the control group, there was significantly worse global mental and physical health decline following COVID-19 (−0.53 and −0.37 T-score points, respectively).

Conclusions and Relevance

A quarter of patients with COVID-19 experienced meaningful reductions in HRQOL. Reductions in global mental and physical health were modest, although significantly worse than a control group. Additionally, identified predictors of patients who worsen may assist clinicians when counseling patients of their risk of worse HRQOL following COVID-19.
Literature
1.
go back to reference Krishnamoorthy Y, Nagarajan R, Saya GK, Menon V. Prevalence of psychological morbidities among general population, healthcare work and COVID-19 patients amidst the COVID-19 pandemic: a systematic review and meta-analysis. Psychiatry Res. 2020;293:113382.CrossRef Krishnamoorthy Y, Nagarajan R, Saya GK, Menon V. Prevalence of psychological morbidities among general population, healthcare work and COVID-19 patients amidst the COVID-19 pandemic: a systematic review and meta-analysis. Psychiatry Res. 2020;293:113382.CrossRef
2.
go back to reference Hu Y, Chen Y, Zheng Y, et al. Factors related to mental health of inpatients with COVID-19 in Wuhan, China. Brain Behav Immun. 2020;89:587-593.CrossRef Hu Y, Chen Y, Zheng Y, et al. Factors related to mental health of inpatients with COVID-19 in Wuhan, China. Brain Behav Immun. 2020;89:587-593.CrossRef
3.
go back to reference Liu CH, Stevens C, Conrad RC, Hahm HC. Evidence for elevated psychiatric distress, poor sleep, and quality of life concerns during the COVID-19 pandemic among U.S. young adults with suspected and reported psychiatric diagnoses. Psychiatry Res. 2020;292:113345.CrossRef Liu CH, Stevens C, Conrad RC, Hahm HC. Evidence for elevated psychiatric distress, poor sleep, and quality of life concerns during the COVID-19 pandemic among U.S. young adults with suspected and reported psychiatric diagnoses. Psychiatry Res. 2020;292:113345.CrossRef
4.
go back to reference Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416-427.CrossRef Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416-427.CrossRef
5.
go back to reference Carvalho-Schneider C, Laurent E, Lemaignen A, et al.Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258-263.CrossRef Carvalho-Schneider C, Laurent E, Lemaignen A, et al.Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258-263.CrossRef
6.
go back to reference Willi S, Luthold R, Hunt A, et al.COVID-19 sequelae in adults aged less than 50 years: a systematic review. Travel Med Infect Dis. 2021;40:101995.CrossRef Willi S, Luthold R, Hunt A, et al.COVID-19 sequelae in adults aged less than 50 years: a systematic review. Travel Med Infect Dis. 2021;40:101995.CrossRef
7.
go back to reference Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2020. Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2020.
8.
go back to reference Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020;17(5). Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020;17(5).
9.
go back to reference Townsend L, Dyer AH, Jones K, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784.CrossRef Townsend L, Dyer AH, Jones K, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784.CrossRef
10.
go back to reference Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-998.CrossRef Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-998.CrossRef
11.
go back to reference Davido B, Seang S, Tubiana R, de Truchis P. Post-COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect. 2020;26(11):1448-1449.CrossRef Davido B, Seang S, Tubiana R, de Truchis P. Post-COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect. 2020;26(11):1448-1449.CrossRef
12.
go back to reference Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013-1022.CrossRef Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013-1022.CrossRef
13.
go back to reference Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study. Int J Environ Res Public Health. 2021;18(4). Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study. Int J Environ Res Public Health. 2021;18(4).
14.
go back to reference van den Borst B, Peters JB, Brink M, et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis. 2020. van den Borst B, Peters JB, Brink M, et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis. 2020.
15.
go back to reference Petersen MS, Kristiansen MF, Hanusson KD, et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis. 2021;73(11):e4058-4063. Petersen MS, Kristiansen MF, Hanusson KD, et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis. 2021;73(11):e4058-4063.
16.
go back to reference Taboada M, Carinena A, Moreno E, et al.Post-COVID-19 functional status six-months after hospitalization. J Infect. 2021;82(4):e31-e33.CrossRef Taboada M, Carinena A, Moreno E, et al.Post-COVID-19 functional status six-months after hospitalization. J Infect. 2021;82(4):e31-e33.CrossRef
17.
go back to reference Weerahandi H, Hochman KA, Simon E, et al.Post-discharge health status and symptoms in patients with severe COVID-19. J Gen Intern Med. 2021;36(3):738-745.CrossRef Weerahandi H, Hochman KA, Simon E, et al.Post-discharge health status and symptoms in patients with severe COVID-19. J Gen Intern Med. 2021;36(3):738-745.CrossRef
18.
go back to reference Ettman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 2020;3(9):e2019686.CrossRef Ettman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 2020;3(9):e2019686.CrossRef
19.
go back to reference Ferreira LN, Pereira LN, da Fe Bras M, Ilchuk K. Quality of life under the COVID-19 quarantine. Qual Life Res. 2021;30(5):1389-1405.CrossRef Ferreira LN, Pereira LN, da Fe Bras M, Ilchuk K. Quality of life under the COVID-19 quarantine. Qual Life Res. 2021;30(5):1389-1405.CrossRef
20.
go back to reference Jehi L, Ji X, Milinovich A, et al.Individualizing risk prediction for positive COVID-19 testing: results from 11,672 patients. Chest. 2020. Jehi L, Ji X, Milinovich A, et al.Individualizing risk prediction for positive COVID-19 testing: results from 11,672 patients. Chest. 2020.
21.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.CrossRef
22.
go back to reference Katzan I, Speck M, Dopler C, et al. The Knowledge Program: an innovative, comprehensive electronic data capture system and warehouse. AMIA Annu Symp Proc. 2011;2011:683-692.PubMedPubMedCentral Katzan I, Speck M, Dopler C, et al. The Knowledge Program: an innovative, comprehensive electronic data capture system and warehouse. AMIA Annu Symp Proc. 2011;2011:683-692.PubMedPubMedCentral
24.
go back to reference Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18(7):873-880.CrossRef Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18(7):873-880.CrossRef
25.
go back to reference Liu H, Cella D, Gershon R, et al. Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel. J Clin Epidemiol. 2010;63(11):1169-1178.CrossRef Liu H, Cella D, Gershon R, et al. Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel. J Clin Epidemiol. 2010;63(11):1169-1178.CrossRef
27.
go back to reference Yuan Y, Yung Y.F., Stokes M. Propensity Score Methods for Causal Inference with the PSMATCH Procedure. Cary, NC SAS Institute Inc.;2017. Yuan Y, Yung Y.F., Stokes M. Propensity Score Methods for Causal Inference with the PSMATCH Procedure. Cary, NC SAS Institute Inc.;2017.
28.
go back to reference Nguyen TL, Collins GS, Spence J, et al.Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance. BMC Med Res Methodol. 2017;17(1):78.CrossRef Nguyen TL, Collins GS, Spence J, et al.Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance. BMC Med Res Methodol. 2017;17(1):78.CrossRef
29.
go back to reference Temperoni C, Grieco S, Pasquini Z, et al. Clinical characteristics, management and health related quality of life in young to middle age adults with COVID-19. BMC Infect Dis. 2021;21(1):134.CrossRef Temperoni C, Grieco S, Pasquini Z, et al. Clinical characteristics, management and health related quality of life in young to middle age adults with COVID-19. BMC Infect Dis. 2021;21(1):134.CrossRef
30.
go back to reference Garrigues E, Janvier P, Kherabi Y, et al.Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4-e6.CrossRef Garrigues E, Janvier P, Kherabi Y, et al.Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4-e6.CrossRef
31.
go back to reference Carfi A, Bernabei R, Landi FGemelli Against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-605.CrossRef Carfi A, Bernabei R, Landi FGemelli Against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-605.CrossRef
32.
go back to reference Nogueira J, Gerardo B, Silva AR, et al. Effects of restraining measures due to COVID-19: pre- and post-lockdown cognitive status and mental health. Curr Psychol. 2021:1-10. Nogueira J, Gerardo B, Silva AR, et al. Effects of restraining measures due to COVID-19: pre- and post-lockdown cognitive status and mental health. Curr Psychol. 2021:1-10.
33.
go back to reference Mazza C, Ricci E, Biondi S, et al. A nationwide survey of psychological distress among Italian people during the COVID-19 pandemic: immediate psychological responses and associated factors. Int J Environ Res Public Health. 2020;17(9). Mazza C, Ricci E, Biondi S, et al. A nationwide survey of psychological distress among Italian people during the COVID-19 pandemic: immediate psychological responses and associated factors. Int J Environ Res Public Health. 2020;17(9).
34.
go back to reference Sams N, Fisher DM, Mata-Greve F, et al. Understanding psychological distress and protective factors amongst older adults during the COVID-19 pandemic. Am J Geriatr Psychiatry. 2021. Sams N, Fisher DM, Mata-Greve F, et al. Understanding psychological distress and protective factors amongst older adults during the COVID-19 pandemic. Am J Geriatr Psychiatry. 2021.
35.
go back to reference Goertz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4). Goertz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4).
36.
go back to reference Blair PW, Brown DM, Jang M, et al. The clinical course of COVID-19 in the outpatient setting: a prospective cohort study. Open Forum Infect Dis. 2021;8(2):ofab007.CrossRef Blair PW, Brown DM, Jang M, et al. The clinical course of COVID-19 in the outpatient setting: a prospective cohort study. Open Forum Infect Dis. 2021;8(2):ofab007.CrossRef
37.
go back to reference Mizrahi B, Shilo S, Rossman H, et al. Longitudinal symptom dynamics of COVID-19 infection. Nat Commun. 2020;11(1):6208.CrossRef Mizrahi B, Shilo S, Rossman H, et al. Longitudinal symptom dynamics of COVID-19 infection. Nat Commun. 2020;11(1):6208.CrossRef
38.
go back to reference Fisher KA, Olson SM, Tenforde MW, et al. Symptoms and recovery among adult outpatients with and without COVID-19 at 11 healthcare facilities-July 2020, United States. Influenza Other Respir Viruses. 2021;15(3):345-351.CrossRef Fisher KA, Olson SM, Tenforde MW, et al. Symptoms and recovery among adult outpatients with and without COVID-19 at 11 healthcare facilities-July 2020, United States. Influenza Other Respir Viruses. 2021;15(3):345-351.CrossRef
39.
go back to reference Lapin BR, Tang WHW, Honomichl R, Hogue O, Katzan IL. Evidence of stability in patient-reported global health during the COVID-19 pandemic. Value Health. 2021;24(11):1578-1585.CrossRef Lapin BR, Tang WHW, Honomichl R, Hogue O, Katzan IL. Evidence of stability in patient-reported global health during the COVID-19 pandemic. Value Health. 2021;24(11):1578-1585.CrossRef
Metadata
Title
Health-Related Quality of Life Mildly Affected Following COVID-19: a Retrospective Pre-post Cohort Study with a Propensity Score–Matched Control Group
Authors
Brittany Lapin, PhD
Irene L. Katzan, MD
Publication date
01-03-2022
Publisher
Springer International Publishing
Keyword
COVID-19
Published in
Journal of General Internal Medicine / Issue 4/2022
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-021-07340-0

Other articles of this Issue 4/2022

Journal of General Internal Medicine 4/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine